HEPATITIS A VIRUS ANTIBODY IGG (HAV IGG) ANTIBODY

The Hepatitis A Virus Antibody IgG (HAV IgG) test detects IgG-class antibodies against hepatitis A virus in a venous blood sample, indicating past infection or established immunity from prior infection or vaccination. Results are reported as reactive/non-reactive or as a quantitative titre depending on the laboratory method, and help clinicians decide on the need for vaccination or further evaluation. This home blood test includes professional phlebotomy and accredited laboratory analysis, delivering reliable results across Dubai and the UAE for travellers, healthcare or food industry workers, and patients with suspected past exposure.

• Anti-HAV IgG (Hepatitis A Virus IgG Antibody)
• Result Interpretation (Reactive / Non‑reactive)
• Quantitative Titre / Index (when available)
• Specimen: Serum (Venous blood)

• To confirm past Hepatitis A infection or natural immunity
• To verify immune response following Hepatitis A vaccination
• Before travel to regions with high HAV prevalence
• After exposure to a confirmed HAV case or during an outbreak
• Screening for healthcare workers, food handlers, or other high‑risk occupations

• At‑home venous blood collection by trained phlebotomists across Dubai and the UAE
• Accredited laboratory testing with reliable turnaround and certified results
• Confirms immunity to avoid unnecessary vaccination or guide clinical care
• Suitable for travel, employment screening, and public health requirements
• Electronic delivery of results compatible with UAE healthcare documentation needs

• At‑home venous blood sample collection by a trained phlebotomist
• No fasting required prior to testing
• Inform the phlebotomist of recent Hepatitis A vaccination or immunoglobulin therapy
• Provide valid Emirates ID or passport and up‑to‑date contact details for reporting